PDT Partners’s SAGENT PHARMACEUTICALS INC COM STK (DE) SGNT Stock Holding History

PDT Partners’s Portfolio SGNT Stock Details SGNT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q3	–	Sell	-56,000	Closed	-$839K	–	544
2016 Q2	$839K	Sell	56,000 -300	-0.5%	-$3.85K	0.07%	276
2016 Q1	$685K	Buy	56,300 +24,800	+79%	+$348K	0.04%	366
2015 Q4	$501K	Buy	+31,500	New	+$496K	0.07%	274
2013 Q4	–	Sell	-62,049	Closed	-$1.27M	–	1403
2013 Q3	$1.27M	Buy	+62,049	New	+$1.38M	0.03%	677

PDT Partners's SGNT Position: Q3 2016 in Review

PDT Partners sold out of SAGENT PHARMACEUTICALS INC COM STK (DE) (SGNT) in Q3 2016, closing a stake of 56,000 shares — an estimated $839K sold.

PDT Partners first reported a position in SGNT in Q3 2013 and held it in 4 quarters. The position peaked at $1.27M in Q3 2013. 0 funds tracked by Wall St. Rank hold SGNT as of Q3 2016.

PDT Partners reported no remaining SAGENT PHARMACEUTICALS INC COM STK (DE) position as of Q3 2016 after selling out during the quarter.
PDT Partners sold 56,000 SAGENT PHARMACEUTICALS INC COM STK (DE) shares in Q3 2016, an estimated $839K.
PDT Partners first reported a position in SAGENT PHARMACEUTICALS INC COM STK (DE) in Q3 2013 and held it in 4 quarters.
PDT Partners's SAGENT PHARMACEUTICALS INC COM STK (DE) position peaked at $1.27M in Q3 2013.
0 funds tracked by Wall St. Rank held SAGENT PHARMACEUTICALS INC COM STK (DE) as of Q3 2016.

Based on PDT Partners's 13F filing for Q3 2016, filed 14 Nov 2016.